Review highlights critical interventions against malaria in affected populations, emphasizing the need for novel antimalarial drugs and multivalent vaccines.
Despite extensive research and various control programs, malaria is still a major global public health threat. It is responsible for approximately 300–500 million clinical cases and 1.2 million deaths annually. To decrease the menace of malaria, it is imperative to regulate the spreading of this formidable disease. This can be accomplished by control of Anopheles mosquito vector by insecticides, reduction of human-vector contact, and prevention and treatment of the disease with antimalarial drugs. New technical approaches are needed to identify novel drug candidates, so that adequate and effective antimalarial drugs can be made available clinically. Besides, a multivalent vaccine that can be effective against multiple stages of the parasite is urgently needed to achieve the goal of complete malaria eradication.
No takes yet. Share an insight, caveat, or question.
Anil Pawar (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: